Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 105

1.

Prognostic impact of neutrophil-to-lymphocyte ratio in gliomas: a systematic review and meta-analysis.

Lei YY, Li YT, Hu QL, Wang J, Sui AX.

World J Surg Oncol. 2019 Aug 31;17(1):152. doi: 10.1186/s12957-019-1686-5. Review.

2.

Prognostic Significance of Neutrophil-to-Lymphocyte Ratio in Colorectal Liver Metastasis: A Systematic Review and Meta-Analysis.

Tang H, Li B, Zhang A, Lu W, Xiang C, Dong J.

PLoS One. 2016 Jul 18;11(7):e0159447. doi: 10.1371/journal.pone.0159447. eCollection 2016. Review.

3.

Prognostic Significance of Preoperative Systemic Cellular Inflammatory Markers in Gliomas: A Systematic Review and Meta-Analysis.

Wang DP, Kang K, Lin Q, Hai J.

Clin Transl Sci. 2019 Sep 24. doi: 10.1111/cts.12700. [Epub ahead of print]

PMID:
31550075
4.
5.

Neutrophil to Lymphocyte Ratio and Platelet to Lymphocyte Ratio as Prognostic Predictors for Hepatocellular Carcinoma Patients with Various Treatments: a Meta-Analysis and Systematic Review.

Zheng J, Cai J, Li H, Zeng K, He L, Fu H, Zhang J, Chen L, Yao J, Zhang Y, Yang Y.

Cell Physiol Biochem. 2017;44(3):967-981. doi: 10.1159/000485396. Epub 2017 Nov 27. Review.

6.

Value of neutrophil-to-lymphocyte ratio for predicting lung cancer prognosis: A meta-analysis of 7,219 patients.

Yu Y, Qian L, Cui J.

Mol Clin Oncol. 2017 Sep;7(3):498-506. doi: 10.3892/mco.2017.1342. Epub 2017 Jul 24.

7.

Pretreatment hematologic markers as prognostic factors in patients with nasopharyngeal carcinoma: A systematic review and meta-analysis.

Su L, Zhang M, Zhang W, Cai C, Hong J.

Medicine (Baltimore). 2017 Mar;96(11):e6364. doi: 10.1097/MD.0000000000006364. Review.

8.

Prognostic significance of neutrophil-to-lymphocyte ratio in rectal cancer: a meta-analysis.

Dong YW, Shi YQ, He LW, Su PZ.

Onco Targets Ther. 2016 May 25;9:3127-34. doi: 10.2147/OTT.S103031. eCollection 2016.

9.

Prognostic role of neutrophil-to-lymphocyte ratio in breast cancer: a systematic review and meta-analysis.

Ethier JL, Desautels D, Templeton A, Shah PS, Amir E.

Breast Cancer Res. 2017 Jan 5;19(1):2. doi: 10.1186/s13058-016-0794-1. Review.

10.

Prognostic role of pretreatment neutrophil-to-lymphocyte ratio in non-small cell lung cancer patients treated with systemic therapy: a meta-analysis.

Wang Z, Zhan P, Lv Y, Shen K, Wei Y, Liu H, Song Y.

Transl Lung Cancer Res. 2019 Jun;8(3):214-226. doi: 10.21037/tlcr.2019.06.10.

11.

Prognostic role of neutrophil lymphocyte ratio in patients with glioma.

Zhang J, Zhang S, Song Y, He M, Ren Q, Chen C, Liu Z, Zeng Y, Xu J.

Oncotarget. 2017 Jul 22;8(35):59217-59224. doi: 10.18632/oncotarget.19484. eCollection 2017 Aug 29.

12.

Prognostic significance of neutrophil-to- lymphocyte ratio in esophageal cancer: a meta-analysis.

Yang X, Huang Y, Feng JF, Liu JS.

Onco Targets Ther. 2015 Apr 10;8:789-94. doi: 10.2147/OTT.S77099. eCollection 2015.

13.

Prognostic significance of neutrophil to lymphocyte ratio in patients with gastrointestinal stromal tumors: A meta-analysis.

Luo XF, Zhou LH.

Clin Chim Acta. 2018 Feb;477:7-12. doi: 10.1016/j.cca.2017.11.029. Epub 2017 Nov 23. Review.

PMID:
29175648
14.

Prognostic significance of elevated pretreatment systemic inflammatory markers for patients with prostate cancer: a meta-analysis.

Peng H, Luo X.

Cancer Cell Int. 2019 Mar 25;19:70. doi: 10.1186/s12935-019-0785-2. eCollection 2019.

15.

Prognostic role of neutrophil to lymphocyte ratio in lung cancers: a meta-analysis including 7,054 patients.

Zhao QT, Yang Y, Xu S, Zhang XP, Wang HE, Zhang H, Wang ZK, Yuan Z, Duan GC.

Onco Targets Ther. 2015 Sep 29;8:2731-8. doi: 10.2147/OTT.S90875. eCollection 2015.

16.

Prognostic significance of neutrophil to lymphocyte ratio in pancreatic cancer: a meta-analysis.

Yang JJ, Hu ZG, Shi WX, Deng T, He SQ, Yuan SG.

World J Gastroenterol. 2015 Mar 7;21(9):2807-15. doi: 10.3748/wjg.v21.i9.2807. Review.

17.

Prognostic significance of pretreatment neutrophil-to-lymphocyte ratio in melanoma patients: A meta-analysis.

Zhan H, Ma JY, Jian QC.

Clin Chim Acta. 2018 Sep;484:136-140. doi: 10.1016/j.cca.2018.05.055. Epub 2018 May 29. Review.

PMID:
29856976
18.

Prognostic roles of neutrophil to lymphocyte ratio and platelet to lymphocyte ratio in ovarian cancer: a meta-analysis of retrospective studies.

Zhao Z, Zhao X, Lu J, Xue J, Liu P, Mao H.

Arch Gynecol Obstet. 2018 Apr;297(4):849-857. doi: 10.1007/s00404-018-4678-8. Epub 2018 Jan 24. Review.

PMID:
29368160
19.

The prognostic significance of preoperative neutrophil-lymphocyte ratio in patients with hepatocellular carcinoma receiving hepatectomy: A systematic review and meta-analysis.

Wang Y, Peng C, Cheng Z, Wang X, Wu L, Li J, Huang C, Guo Q, Cai H.

Int J Surg. 2018 Jul;55:73-80. doi: 10.1016/j.ijsu.2018.05.022. Epub 2018 May 19. Review.

PMID:
29787804
20.

Prognostic role of pretreatment blood neutrophil-to-lymphocyte ratio in advanced cancer survivors: A systematic review and meta-analysis of 66 cohort studies.

Mei Z, Shi L, Wang B, Yang J, Xiao Z, Du P, Wang Q, Yang W.

Cancer Treat Rev. 2017 Jul;58:1-13. doi: 10.1016/j.ctrv.2017.05.005. Epub 2017 May 29. Review.

PMID:
28602879

Supplemental Content

Support Center